PEAK6’s Gilead Sciences GILD Stock Holding History

PEAK6’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-34,100	Closed	-$3.78M	–	3135
2025 Q2	$3.78M	Sell	34,100 -140,900	-81%	-$15M	0.01%	1108
2025 Q1	$19.6M	Buy	175,000 +145,000	+483%	+$15M	0.04%	345
2024 Q4	$2.77M	Buy	+30,000	New	+$2.7M	0.01%	1232

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

PEAK6's GILD Position: Q1 2026 in Review

PEAK6 opened a new position in Gilead Sciences (GILD) in Q1 2026: 7,597 shares worth $1.06M. The stake represents ﹤0.01% of the portfolio and ranks #1675 among its holdings.

2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

PEAK6 held 7,597 shares of Gilead Sciences worth $1.06M as of Q1 2026.
Gilead Sciences was a new PEAK6 position in Q1 2026.
Gilead Sciences made up ﹤0.01% of PEAK6's portfolio in Q1 2026, its #1675 holding.
2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on PEAK6's 13F filing for Q1 2026, filed 14 May 2026.